BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan · Delayed Price · Currency is JPY 45.00
+2.00 (4.65%)
Oct 9, 2026, 3:30 PM JST
TYO:4594 Market Cap
TYO:4594 has a market cap or net worth of 6.25 billion as of October 9, 2026. It is the 32,124th most valuable company in the world and the 2,924th biggest in Japan. Its market cap has increased by 6.26% in one year.
Market Cap
6.25B
Enterprise Value
4.09B
Revenue
84.00K
Global Rank
Country Rank
#2,924 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 22, 2015, TYO:4594's market cap has decreased from 13.23B to 6.25B, a decrease of -52.77%. That is a compound annual growth rate of -6.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 6.25B | 16.89% |
| Dec 30, 2025 | 5.35B | 37.06% |
| Dec 30, 2024 | 3.90B | -28.70% |
| Dec 29, 2023 | 5.47B | -13.00% |
| Dec 30, 2022 | 6.29B | 7.22% |
| Dec 30, 2021 | 5.87B | -35.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carna Biosciences | 7.67B |
| J-Pharma | 7.64B |
| StemCell Institute | 7.58B |
| ADR Biomedical Holdings | 6.96B |
| MEDINET | 6.81B |
| SUSMED,Inc. | 6.73B |
| Cyfuse Biomedical K.K. | 6.28B |
| CellSource | 6.17B |